Literature DB >> 1696331

Homing to central nervous system vasculature by antigen-specific lymphocytes. I. Localization of 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis.

A H Cross1, B Cannella, C F Brosnan, C S Raine.   

Abstract

Chronic relapsing experimental allergic encephalomyelitis was induced by the passive transfer of [14C]thymidine-labeled myelin basic protein (MBP)-sensitized lymphocytes from MBP-immunized mice to naive syngeneic recipients. Labeled lymphocytes were localized and quantitated in the central nervous system during acute and chronic disease and clinical relapses. The results have shown that MBP-immune T cells home to the central nervous system endothelium 24 hours prior to and during initial clinical disease (5 to 7 days posttransfer). Unexpectedly, labeled MBP-immune cells never migrated far from blood vessels and, despite the presence of massive parenchymal inflammatory cell infiltration, almost invariably remained within the perivascular area. Quantitation revealed that labeled cells represented a minority (usually 1% to 4%) of the inflammatory cells during acute and early chronic disease. Furthermore, labeled cells could not be demonstrated in the central nervous system at the time of clinical relapse. We conclude that in this model, MBP-immune lymphocytes act exclusively from a perivascular location to orchestrate the influx of inflammatory cells that are predominantly of recipient derivation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1696331

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  54 in total

1.  Breakdown of the blood-retinal barrier induced by activated T cells of nonneural specificity.

Authors:  P Hu; J D Pollard; T Chan-Ling
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

2.  Pathogenesis of multiple sclerosis.

Authors:  R A Hughes
Journal:  J R Soc Med       Date:  1992-07       Impact factor: 5.344

3.  A lymphocyte homing receptor (L-selectin) mediates the in vitro attachment of lymphocytes to myelinated tracts of the central nervous system.

Authors:  K Huang; J S Geoffroy; M S Singer; S D Rosen
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

4.  Comparative analysis of lesion development and intraspinal inflammation in four strains of mice following spinal contusion injury.

Authors:  Kristina A Kigerl; Violeta M McGaughy; Phillip G Popovich
Journal:  J Comp Neurol       Date:  2006-02-01       Impact factor: 3.215

5.  Central nervous system endothelial cell-polymorphonuclear cell interactions during autoimmune demyelination.

Authors:  A H Cross; C S Raine
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

Review 6.  Mechanisms of immune-mediated demyelinating disease of the central nervous system.

Authors:  D Baker; A N Davison
Journal:  Neurochem Res       Date:  1991-09       Impact factor: 3.996

7.  Staphylococcal enterotoxin B-specific adhesion of murine splenic T cells to a human endothelial cell line.

Authors:  M Kita; K Eguchi; Y Kawabe; T Tsukada; K Migita; A Kawakami; N Matsuoka; S Nagataki
Journal:  Immunology       Date:  1996-07       Impact factor: 7.397

8.  In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases.

Authors:  H Koprowski; Y M Zheng; E Heber-Katz; N Fraser; L Rorke; Z F Fu; C Hanlon; B Dietzschold
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

9.  T-cell receptor (TCR) usage in Lewis rat experimental autoimmune encephalomyelitis: TCR beta-chain-variable-region V beta 8.2-positive T cells are not essential for induction and course of disease.

Authors:  R Gold; G Giegerich; H P Hartung; K V Toyka
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

10.  An interferon-inducible molecule on brain endothelium which controls lymphocyte adhesion mediated by integrins.

Authors:  D Male; J Rahman; A Linke; W Zhao; W Hickey
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.